Skip to content
Log in
Sponsored Have an interesting project or opportunity? → Hire me ↗
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Efficient in vivo cytosine base editing using virus-like particles with uracil DNA glycosylase inhibition.

Junjie Zhu Lin Ding Kai Liu Xingyu Zhu Jifang Li Buer Ha Bao-Qing Gao Xujiao Zhou Chengfang Liu Jia Wei Shuangyu Ma Wenchao Xu Lingyun Kong Jing Wu Xiaodun Mou Bei Yang Lijie Wang Jiaxu Hong Li Yang Jia Chen
Jul 2026 · Nature Biotechnology · 0 citations · 67 references
Medicine
DOI PubMed Semantic Scholar
View source

Similar papers

Open access Aug 2026

Virus-like particle-delivered base editor collection to expand the genome engineering toolbox

It is revealed that a wide variety of mutation types are possible with the base editors in this VLP collection, revealing that a wide variety of mutation types are possible with the base editors in this collection.

Asfar Lathif Salaudeen, Trevor Shyiak, Carl G. de Boer · 0 citations
Open access Aug 2026

Compact 9dBEs Enable Efficient and Precise Genome Editing in Mammalian Cells and In Vivo

An efficient Cas9d system (Cas9dUltra) is developed through gRNA and protein engineering, and its base editors (9dBEs) further developed through gRNA and protein engineering, enabling efficient and precise genome editing in human cells.

Qingquan Xiao, Zhijin Tian, Luqi Weng et al. · 0 citations
Jul 2026

Development and Characterization of RNA Aptamer-Mediated Modular Base Editors Containing Staphylococcus aureus Cas9 Derivatives and Novel Deaminase Orthologs

The effectiveness of the SaCas9 modular base editors, the robustness of the platform’s modularity, and its feasibility for convenient screening of target-specific base editors are demonstrated.

J. Collantes, Kellen Xu, M. Ruiz-Urigüen et al. · 0 citations
Review Aug 2026

Recent advances in base editing technology and its applications in disease therapy.

This review focuses on the action mode of different base editors, highlights their interplays with the TLS, summarizes their potential therapeutic applications and discusses perspective strategies to improve precision and expand targeting scope.

Rui Tao, Min Li, Tongyun Luo et al. · 0 citations
Open access Jul 2026

Engineered ADARs enable precision A-to-G base editing of DNA.

A single-nucleotide resolution ABE created by fusing a nickase Cas9, nCas9-H840A, with the deaminase domain of ADAR, which acts on DNA:RNA hybrids, instead of TadA, which acts on single-stranded DNA in conventional ABEs.

Hyeon Woo Im, Bada Jeong, Yeji Lee et al. · 1 citation
Review Open access Jul 2026

Base editing for precision therapeutics.

Key remaining challenges include bystander editing within the activity window, residual off-target DNA and RNA editing, delivery constraints, delivery constraints, immunogenicity, and the need for durable long-term safety evidence across relevant cell types and disease contexts.

Moksada Regmi, K. Ma, C. Bi et al. · 0 citations